Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152360 | SCV000201280 | uncertain significance | not specified | 2014-05-09 | criteria provided, single submitter | clinical testing | The Glu10759Gly variant in TTN has not been previously reported in individuals w ith cardiomyopathy, but has been identified in 1/128 Mexican chromosomes by the 1000 Genomes Project (dbSNP rs190461403). Computational prediction tools and con servation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Glu10759Gly variant is un certain. |
Gene |
RCV001704102 | SCV000237132 | likely benign | not provided | 2019-12-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000228409 | SCV000286636 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-12-20 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001704102 | SCV003826622 | uncertain significance | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing |